Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Bullboard Posts
Comment by Indomitableon Jun 02, 2016 11:00pm
87 Views
Post# 24929943

RE:from MD&A on Sedar May 30th

RE:from MD&A on Sedar May 30th
"Management has a plan in place to address this concern and intends to obtain 
additional funds by equity financing to the extent there is a shortfall from operations." 

For some reason it seems you failed to mention this part above. I just copied that out of the May 30th financials under the heading a) Going  Concern of Operations, taken out of this paragraph following...

"The  Company’s  ability  to  continue  as  a  going  concern  is  dependent  upon  its  ability  to  generate  future  profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.  Management has a plan in place to address this concern and intends to obtain additional funds by equity financing to the extent there is a shortfall from operations.  While the Company is continuing its best efforts to achieve the above plans, there is no assurance that any such activity will generate funds for operations. "
 
It's funny how some people only say part of the facts. Withholding relevant pieces of information from expounded fact is also known as a form of a lie or fallacy in philosophy. 

There is risk in all stocks. There are no gaurantees. If you look at any research and development company which are in the phase 1, phase 2, phase 3 development before their product is finally out there and selling, they all have issues with financing. You will see those going concern of operations in almost all research and development companies financials until the point that their product is finally out there and selling or they get bought out by another company. 

Any company out there like Replicel which actually are currently successful and have products out there which they are selling, those companies had to start out at the beginning just like Replicel and figure out where to get financing until they could stand on their own two legs and support themselves with their own products. 

It's not like Replicel just fell off the turnip truck yesterday. Do your dd on them.

I'm still in and holding long term.  I support this company. 

Indomitable Cool

Bullboard Posts